| Name | Title | Contact Details |
|---|---|---|
Mark Buttkus |
Chief Technology Officer | Profile |
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
Visiting Nurse Association of Ohio is the largest non-profit, community-based healthcare organization in Ohio and has been helping patients for more than 100 years. VNA of Ohio works with hospitals, doctors, community agencies and companies to provide services for patients in their homes including skilled nursing care, hospice, mental health services, rehabilitation therapies, chronic disease management and personal care assistance. With nearly 600 employees, VNA of Ohio provides high-quality, comprehensive home health and hospice care to promote optimal health, independence and dignity of those living in the communities we serve.
Exemplar Pharmaceuticals is a Fall River, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
FluGen is driving the development of a universal flu vaccine to advance human health.
Sharp Surgical Repair Inc is a Oyster Bay, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.